LORRAIN DANIEL S. (Chief Scientific Officer) sold 2.7% of their position (4.17K shares) of CONTINEUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $56.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001628280-26-023949
Officer· Chief Scientific Officer
Since Mar 2026
-4.17K
Net shares
Net seller
$56.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.17K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−4.17K
Price / share
$13.43
Trade value
$56.01K
% of position
2.7%
4/6/2026
151.88K→147.71K
Total
Net shares
−4.17K
Net value
-$56.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/6/2026 | S · Sale | −4.17K | $13.43 | $56.01K | 2.7% | 151.88K | 147.71K |
| Total | −4.17K | -$56.01K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned6.84K
Total
6.84K indirect6.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 6.84K | Indirect |
| Total | 6.84K | 6.84K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported